Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile
Articles by Allison Dunning
‘Thank you for sharing. Do you have a plan?’ Outdated policies preventing peer supporters from saving lives
I recently had the honour of co-facilitating a conversation about death and dying with a group of peer support workers from across Canada. We recognized there wasn’t space being made for peer support workers to support their peers with conversations around MAiD, death and dying, and so we worked to create one.
The burden of non‐cardiac comorbidities and association with clinical outcomes in an acute heart failure trial - insights from ASCEND‐HF
Research Article Robert J. Mentz Corresponding Author E-mail address: robert.mentz@duke.edu Division of Cardiology, Duke University Medical Center, Duke Clinical Research Institute, Durham, NC, USA Corresponding author. Duke Clinical Research Institute, PO Box 17 969, Durham, NC 27715, USA. Tel: +1 919 668‐7121, Fax: +1 919 668‐7063, Email: robert.mentz@duke.edu Search for more papers by this author Abstract Aims Non‐cardiac comorbidities are highly prevalent in patients with heart failure (HF).
Causes of Death in a Contemporary Cohort of Patients With Type 2 Diabetes and Atherosclerotic Cardiovascular Disease: Insights From the TECOS Trial
Causes of Death in a Contemporary Cohort of Patients With Type 2 Diabetes and Atherosclerotic Cardiovascular Disease: Insights From the TECOS Trial Abhinav Sharma, Jennifer B. Green, Allison Dunning, Yuliya Lokhnygina, Sana M. Al-Khatib, Renato D. Lopes, John B. Buse, John M. Lachin, Frans Van de Werf, Paul W. Armstrong, Keith D. Kaufman, Eberhard Standl, Juliana C.N. Chan, Larry A. Distiller, Russell Scott, Eric D. Peterson, Rury R. Holman Diabetes Care Dec 2017, 40 (12) 1763-1770; DOI: 10.2337/dc17-1091
Aetiology, timing and clinical predictors of early vs. late readmission following index hospitalization for acute heart failure: insights from ASCEND‐HF - Fudim - 2018 - European Journal of Heart Failure - Wiley Online Library
Timing and cause of readmission in the ASCEND‐HF (Acute Study of Clinical Effectiveness of Nesiritide and Decompensated Heart Failure) trial were assessed. Early and late readmissions were defined as admissions occurring within 0–7 days and 8–30 days post‐discharge, respectively. Patients who died in hospital or remained hospitalized at day 30 post‐randomization were excluded. Patients were compared by timing and cause of readmission.
Show More
loading
Actions
Is this you?
As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.Get in touch with Allison
Contact Allison, search articles and posts on X, monitor coverage, and track replies from one place.
Learn more about Muck Rack